Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

2,082 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,082 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06223958
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 344
Not applicableStudy completedNCT05202587
What this trial is testing

The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 386
Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Testing effectiveness (Phase 2)Study completedNCT04820452
What this trial is testing

IBI302 in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 231
Post-approval studies (Phase 4)Active Not RecruitingNCT06795048
What this trial is testing

Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 274
Not applicableStudy completedNCT01581606
What this trial is testing

Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 169
Not applicableStudy completedNCT01915238
What this trial is testing

Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study

Who this might be right for
AMDAge- Related Macular Degeneration
National Eye Institute (NEI) 52
Testing effectiveness (Phase 2)Study completedNCT02732899
What this trial is testing

Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD

Who this might be right for
Exudative Age Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 20
Not applicableStudy completedNCT02556723
What this trial is testing

Intravitreal Injections of Ziv-aflibercept for Macular Diseases

Who this might be right for
Diabetic Macular EdemaAge Related Macular DegenerationBranch Retinal Vein Occlusion With Macular Edema+1 more
Retina Clinic, Sao Paulo, Brazil 60
Not applicableStudy completedNCT05927740
What this trial is testing

The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in Pregnancy

Who this might be right for
Corneal DystrophyMacular DystrophyHyperemesis Gravidarum - Severe
Batman Training and Research Hospital 110
Not applicableActive Not RecruitingNCT04065490
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300476
What this trial is testing

Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

Who this might be right for
Stargardt Disease 1
West China Hospital 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06864988
What this trial is testing

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Neovascularization Secondary to Age-Related Macular Degeneration
4D Molecular Therapeutics 480
Testing effectiveness (Phase 2)Study completedNCT00043680
What this trial is testing

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 60
Testing effectiveness (Phase 2)Study completedNCT02484690
What this trial is testing

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal Neovascularization
Hoffmann-La Roche 273
Testing effectiveness (Phase 2)Ended earlyNCT00857259
What this trial is testing

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Choroidal Neo-Vascular Age-onset Macular DegenerationAge-related Macular Degeneration
Novartis Pharmaceuticals 16
Post-approval studies (Phase 4)Study completedNCT02559180
What this trial is testing

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab

Who this might be right for
Diabetic RetinopathyMacular Edema
Rishi Singh 20
Very early researchStudy completedNCT04590196
What this trial is testing

Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
University of Illinois at Chicago 10
Not applicableUnknownNCT05222997
What this trial is testing

Therapy of Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Robert Hörantner 150
Post-approval studies (Phase 4)Study completedNCT02125864
What this trial is testing

Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 16
Next Page